Breaking News

Tuesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
AKRX

Akorn

$3.60

0.15 (4.35%)

16:30
03/19/19
03/19
16:30
03/19/19
16:30
Initiation
Akorn initiated at SunTrust »

Akorn initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 01

    May

Over a week ago
BAX

Baxter

$75.62

0.48 (0.64%)

, AKRX

Akorn

$3.73

0.03 (0.81%)

15:23
03/12/19
03/12
15:23
03/12/19
15:23
Periodicals
Baxter tells Bloomberg not in talks with Akorn, has no plans to submit offer »

A spokeswoman for Baxter…

BAX

Baxter

$75.62

0.48 (0.64%)

AKRX

Akorn

$3.73

0.03 (0.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Mar

  • 01

    May

AKRX

Akorn

$3.86

0.16 (4.32%)

, BAX

Baxter

$75.58

0.44 (0.59%)

12:23
03/12/19
03/12
12:23
03/12/19
12:23
Hot Stocks
Akorn higher after Intereconomia claims Baxter near takeover deal »

Shares of Akorn (AKRX)…

AKRX

Akorn

$3.86

0.16 (4.32%)

BAX

Baxter

$75.58

0.44 (0.59%)

FSNUY

Fresenius SE

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Mar

  • 01

    May

BAX

Baxter

$75.57

0.43 (0.57%)

, AKRX

Akorn

$3.85

0.145 (3.92%)

12:11
03/12/19
03/12
12:11
03/12/19
12:11
Periodicals
Baxter in advanced talks to buy Akorn, Intereconomia reports »

Baxter (BAX) is in…

BAX

Baxter

$75.57

0.43 (0.57%)

AKRX

Akorn

$3.85

0.145 (3.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Mar

  • 01

    May

AKRX

Akorn

$3.84

0.07 (1.86%)

, FSNUY

Fresenius SE

$0.00

(0.00%)

12:00
03/11/19
03/11
12:00
03/11/19
12:00
Periodicals
Akorn off lows after Vox Markets blog speculates on takeover rumors »

Following the collapse of…

AKRX

Akorn

$3.84

0.07 (1.86%)

FSNUY

Fresenius SE

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

AKRX

Akorn

$3.77

0.125 (3.43%)

08:10
03/11/19
03/11
08:10
03/11/19
08:10
Recommendations
Akorn analyst commentary at JMP Securities »

Akorn is currently fairly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

AKRX

Akorn

$4.28

0.24 (5.94%)

, FSNUY

Fresenius SE

$0.00

(0.00%)

17:20
03/01/19
03/01
17:20
03/01/19
17:20
Hot Stocks
Akorn confirms favorable ruling from Delaware Court »

Akorn (AKRX) announced …

AKRX

Akorn

$4.28

0.24 (5.94%)

FSNUY

Fresenius SE

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

AKRX

Akorn

$3.51

-0.29 (-7.63%)

, FSNUY

Fresenius SE

$0.00

(0.00%)

10:00
02/28/19
02/28
10:00
02/28/19
10:00
Periodicals
Judge denies Fresenius fraud claim against Akorn, Bloomberg reports »

A Delaware judge denied…

AKRX

Akorn

$3.51

-0.29 (-7.63%)

FSNUY

Fresenius SE

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 01

    May

AKRX

Akorn

$3.80

-0.32 (-7.77%)

08:04
02/28/19
02/28
08:04
02/28/19
08:04
Hot Stocks
Akorn received Form 483 from FDA over New York manufacturing facility »

Akorn disclosed that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 01

    May

AKRX

Akorn

$3.80

-0.32 (-7.77%)

07:58
02/28/19
02/28
07:58
02/28/19
07:58
Periodicals
FDA highlights sanitation concerns at Akorn's Amityville plant, Reuters reports »

Akorn says that the FDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 01

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.